Replies

Claim/Topic	Summary	Veracity	Explanation
Tylenol (acetaminophen) connection to ACE inhibitors	Questions link between Tylenol's liver enzyme inhibition and ACE inhibitors; speculates on pain via ACE2.	FALSE	No established connection; acetaminophen's liver effects are via CYP enzymes, unrelated to ACE inhibitors. Pain mechanisms involve TRPV1, CB1, serotonergic, and COX, not ACE2.
IVM/HCQ block/clear ACE2 to control pain signals	Suggests antiparasitics like IVM/HCQ block ACE2 from spike proteins to manage pain.	Partially True (for blocking, not pain)	IVM docks to spike-ACE2 complex, potentially inhibiting binding; HCQ interferes with ACE2 glycosylation and entry. No evidence for pain control via this mechanism.
Vaccines cause spike protein overload like allergy	Posits vaccines overwhelm immune system with excess spikes, exacerbating allergic response without curing.	Misleading	Vaccines induce immune response to spikes; rare hypersensitivity occurs, but not systemic "overload" like seasonal allergy. Some IgG4 shift may induce tolerance, not overwhelm.
Acetaminophen mechanisms and non-ACE involvement	Discusses acetaminophen's analgesia via serotonergic, CB1, TRPV1, COX, and DAGLα inhibition, distinct from ACE.	True	Accurate summary of known mechanisms; no ACE receptor role in pain relief.
Acetaminophen as "ACE2 NSAID" for upper body pain	Claims acetaminophen targets ACE2/ACE1 for pain above pelvis/mid-thoracic; calls it ACE2 NSAID.	FALSE	Not an NSAID (inhibits COX weakly, no anti-inflammatory); no evidence for ACE2 in regional pain relief.
NSAIDs tied to ACE receptors co-opted by vaccine spikes	All NSAID relief linked to ACE receptors "filled" by vaccine spikes, delaying immunity.	FALSE	NSAIDs act via COX inhibition; spikes bind ACE2 for entry, may evade immunity, but no direct co-opting of NSAID pathways.
IVM preempts vaccine damage by occupying ACE2	Gave IVM pre/post-vaccine to block spike docking on ACE2, protecting reproduction.	Misleading	IVM inhibits spike-ACE2 binding via spike RBD, not direct ACE2 occupancy; prophylactic use unproven for vaccine side effects.
Prilosec (omeprazole) banned OTC due to ACE2/cancer	Claims Prilosec acts on ACE2, banned OTC as "cancerous" to suppress COVID info.	FALSE	Omeprazole is OTC since 2003; long-term PPI use linked to risks (not banned), no ACE2 suppression motive or ban.
Lisinopril as ACE2 inhibitor	Refers to Lisinopril as an "ACE2 inhibitor."	FALSE	Lisinopril is an ACE (ACE1) inhibitor; it may upregulate ACE2 expression.
Protecting ACE2 defeats COVID naturally	Clearing/protecting ACE2 allows natural defeat of COVID, as in unvaccinated.	Misleading	Blocking ACE2 prevents viral entry but impairs its protective roles (e.g., anti-inflammation); immunity defeats virus via antibodies/T-cells, not just ACE2.

Claims Analysis Table
Claim/Topic Summary Veracity Explanation
Tylenol (acetaminophen) connection to ACE inhibitors Questions link between Tylenol's liver enzyme inhibition and ACE inhibitors; speculates on pain via ACE2. FALSE No established connection; acetaminophen's liver effects are via CYP enzymes, unrelated to ACE inhibitors. Pain mechanisms involve TRPV1, CB1, serotonergic, and COX, not ACE2.
IVM/HCQ block/clear ACE2 to control pain signals Suggests antiparasitics like IVM/HCQ block ACE2 from spike proteins to manage pain. Partially True (for blocking, not pain) IVM docks to spike-ACE2 complex, potentially inhibiting binding; HCQ interferes with ACE2 glycosylation and entry. No evidence for pain control via this mechanism.
Vaccines cause spike protein overload like allergy Posits vaccines overwhelm immune system with excess spikes, exacerbating allergic response without curing. Misleading Vaccines induce immune response to spikes; rare hypersensitivity occurs, but not systemic "overload" like seasonal allergy. Some IgG4 shift may induce tolerance, not overwhelm.
Acetaminophen mechanisms and non-ACE involvement Discusses acetaminophen's analgesia via serotonergic, CB1, TRPV1, COX, and DAGLα inhibition, distinct from ACE. True Accurate summary of known mechanisms; no ACE receptor role in pain relief.
Acetaminophen as "ACE2 NSAID" for upper body pain Claims acetaminophen targets ACE2/ACE1 for pain above pelvis/mid-thoracic; calls it ACE2 NSAID. FALSE Not an NSAID (inhibits COX weakly, no anti-inflammatory); no evidence for ACE2 in regional pain relief.
NSAIDs tied to ACE receptors co-opted by vaccine spikes All NSAID relief linked to ACE receptors "filled" by vaccine spikes, delaying immunity. FALSE NSAIDs act via COX inhibition; spikes bind ACE2 for entry, may evade immunity, but no direct co-opting of NSAID pathways.
IVM preempts vaccine damage by occupying ACE2 Gave IVM pre/post-vaccine to block spike docking on ACE2, protecting reproduction. Misleading IVM inhibits spike-ACE2 binding via spike RBD, not direct ACE2 occupancy; prophylactic use unproven for vaccine side effects.
Prilosec (omeprazole) banned OTC due to ACE2/cancer Claims Prilosec acts on ACE2, banned OTC as "cancerous" to suppress COVID info. FALSE Omeprazole is OTC since 2003; long-term PPI use linked to risks (not banned), no ACE2 suppression motive or ban.
Lisinopril as ACE2 inhibitor Refers to Lisinopril as an "ACE2 inhibitor." FALSE Lisinopril is an ACE (ACE1) inhibitor; it may upregulate ACE2 expression.
Protecting ACE2 defeats COVID naturally Clearing/protecting ACE2 allows natural defeat of COVID, as in unvaccinated. Misleading Blocking ACE2 prevents viral entry but impairs its protective roles (e.g., anti-inflammation); immunity defeats virus via antibodies/T-cells, not just ACE2.